DPI Media
Stay updated with our latest news and media
Inside Glimpse into Nabota’s State-of-the-Art Biomanufacturing Facility in South Korea
Writer
Manager
July 16, 2025
News Anchor 1:
With high quality, South Korea has become a global leader in the aesthetics industry.
News Anchor 2:
Yes, in Indonesia, the K-beauty market continues to grow every year.

Reporter:
Indonesia is one of the fastest-growing aesthetic markets in Southeast Asia. The beauty and personal care industry is projected to reach 9.74 billion US dollars by 2025. South Korea is recognized as a global leader in aesthetic innovation. Indonesia’s K-beauty market reached 86.3 million US dollars in 2023 and is projected to double in the next ten years. As a global hub for aesthetics, South Korea continues to strengthen its influence in Southeast Asia, including Indonesia.

Junsu Yoon (Head of Nabota Business Division):
Subtitle: Daewoong’s global botulinum toxin product has reached more than 80 countries, including the United States and Latin America. In Indonesia, Daewoong’s botulinum toxin has received official approval from the National Agency of Drug and Food Control (BPOM). Through various scientific meetings and symposiums, the product has attracted significant attention from local medical professionals.

Reporter:
Products are developed in automated facilities with integrated quality systems and advanced technology, adhering to the highest standards in the global aesthetics industry. Daewoong is also preparing Building I to meet global demand.

Sangki Kim (Center Head Nabota Production Center):
The botulinum toxin manufacturing Building C, which is currently in commercial production, has passed the highest global quality standards, earning cGMP certification from the U.S. FDA. Building I, where you are now, is a new facility capable of producing 6.5 million vials per year on a single production line.

Reporter:
With injectable procedures becoming more popular, Indonesia’s medical aesthetics market is projected to reach 495 million US dollars by 2029.